using semaglutide short term for Weight Loss: A Comprehensive Guide Short-Term GLP-1 Use: One-Month Semaglutide

doi: 10.1016/j.ejphar.2020.173581 124 Barreto-ViannaARCAguilaMBMandarim-de-LacerdaCA

Weeks 1-8 (highest risk period): GI side effects are at their peak during initial dose escalation

The safety of SOLIQUA 100/33 (n=834, with a mean treatment duration of 203 days) has been evaluated in two clinical studies (30 weeks duration) in type 2 diabetes patients

Mounjaro (tirzepatide) is a new, injectable medication indicated for use in patients with type 2 diabetes

These may still apply to legacy contracts, but for Medicare Advantage plan year 2025 onward, V28 applies

Coming soon - New 7.2mg dose of Wegovy Similar weight loss to Mounjaro 15mg Already approved in the U.S